TY - JOUR
T1 - Cognitive impairment in people living with HIV
T2 - consensus recommendations for a new approach
AU - Nightingale, Sam
AU - Ances, Beau
AU - Cinque, Paola
AU - Dravid, Ameet
AU - Dreyer, Anna J.
AU - Gisslén, Magnus
AU - Joska, John A.
AU - Kwasa, Judith
AU - Meyer, Ana Claire
AU - Mpongo, Nombeko
AU - Nakasujja, Noeline
AU - Pebody, Roger
AU - Pozniak, Anton
AU - Price, Richard W.
AU - Sandford, Christopher
AU - Saylor, Deanna
AU - Thomas, Kevin G.F.
AU - Underwood, Jonathan
AU - Vera, Jaime H.
AU - Winston, Alan
N1 - Publisher Copyright:
© 2023, Springer Nature Limited.
PY - 2023/7
Y1 - 2023/7
N2 - Current approaches to classifying cognitive impairment in people living with HIV can overestimate disease burden and lead to ambiguity around disease mechanisms. The 2007 criteria for HIV-associated neurocognitive disorders (HAND), sometimes called the Frascati criteria, can falsely classify over 20% of cognitively healthy individuals as having cognitive impairment. Minimum criteria for HAND are met on the basis of performance on cognitive tests alone, which might not be appropriate for populations with diverse educational and socioeconomic backgrounds. Imprecise phenotyping of cognitive impairment can limit mechanistic research, biomarker discovery and treatment trials. Importantly, overestimation of cognitive impairment carries the risk of creating fear among people living with HIV and worsening stigma and discrimination towards these individuals. To address this issue, we established the International HIV-Cognition Working Group, which is globally representative and involves the community of people living with HIV. We reached consensus on six recommendations towards a new approach for diagnosis and classification of cognitive impairment in people living with HIV, intended to focus discussion and debate going forward. We propose the conceptual separation of HIV-associated brain injury — including active or pretreatment legacy damage — from other causes of brain injury occurring in people living with HIV. We suggest moving away from a quantitative neuropsychological approach towards an emphasis on clinical context. Our recommendations are intended to better represent the changing profile of cognitive impairment in people living with HIV in diverse global settings and to provide a clearer framework of classification for clinical management and research studies.
AB - Current approaches to classifying cognitive impairment in people living with HIV can overestimate disease burden and lead to ambiguity around disease mechanisms. The 2007 criteria for HIV-associated neurocognitive disorders (HAND), sometimes called the Frascati criteria, can falsely classify over 20% of cognitively healthy individuals as having cognitive impairment. Minimum criteria for HAND are met on the basis of performance on cognitive tests alone, which might not be appropriate for populations with diverse educational and socioeconomic backgrounds. Imprecise phenotyping of cognitive impairment can limit mechanistic research, biomarker discovery and treatment trials. Importantly, overestimation of cognitive impairment carries the risk of creating fear among people living with HIV and worsening stigma and discrimination towards these individuals. To address this issue, we established the International HIV-Cognition Working Group, which is globally representative and involves the community of people living with HIV. We reached consensus on six recommendations towards a new approach for diagnosis and classification of cognitive impairment in people living with HIV, intended to focus discussion and debate going forward. We propose the conceptual separation of HIV-associated brain injury — including active or pretreatment legacy damage — from other causes of brain injury occurring in people living with HIV. We suggest moving away from a quantitative neuropsychological approach towards an emphasis on clinical context. Our recommendations are intended to better represent the changing profile of cognitive impairment in people living with HIV in diverse global settings and to provide a clearer framework of classification for clinical management and research studies.
UR - http://www.scopus.com/inward/record.url?scp=85163054299&partnerID=8YFLogxK
U2 - 10.1038/s41582-023-00813-2
DO - 10.1038/s41582-023-00813-2
M3 - Article
C2 - 37311873
AN - SCOPUS:85163054299
SN - 1759-4758
VL - 19
SP - 424
EP - 433
JO - Nature Reviews Neurology
JF - Nature Reviews Neurology
IS - 7
ER -